Fortis Healthcare Ltd Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Cr

Consolidate Annual Results

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Mar'19

Net Sales

7,782.75

6,892.92

6,297.63

5,717.61

4,030.12

4,632.32

4,469.36

Other Operating Income

0.00

Total Operating income

7,782.75

6,892.92

6,297.63

5,717.61

4,030.12

4,632.32

4,469.36

Raw Material Cost

1,838.07

1,603.25

1,454.65

1,403.37

975.90

963.85

928.24

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

-7.88

15.43

0.06

-46.14

0.00

Employee Cost

1,167.24

1,119.53

1,046.88

972.94

849.01

916.03

913.59

Power Cost

0.00

Manufacturing Expenses

1,630.62

1,459.51

1,311.46

1,101.30

808.97

975.89

1,188.05

Selling and Distribution Expenses

0.00

Other Expenses

1,566.76

1,427.56

1,383.24

1,217.18

991.80

1,167.03

1,214.26

Total Expenditure (Excl Depreciation)

6,194.81

5,625.28

5,196.29

4,648.65

3,625.68

4,022.80

4,244.14

Operating Profit (PBDIT) excl Other Income

1,587.94

1,267.64

1,101.34

1,068.96

404.44

609.52

225.22

Other Income

66.94

38.25

61.72

27.34

46.56

52.64

92.40

Operating Profit (PBDIT)

1,654.88

1,305.89

1,163.06

1,096.30

451.00

662.16

317.62

Interest

184.41

130.95

129.09

146.85

165.88

205.06

336.83

Exceptional Items

-89.34

16.02

73.61

315.03

1.21

61.83

-222.38

Gross Profit (PBDT)

1,381.13

1,190.96

1,107.58

1,264.48

286.33

518.93

-241.59

Depreciation

385.61

342.50

315.74

300.84

290.60

291.73

232.92

Profit Before Tax

995.52

848.46

791.84

963.64

-4.27

227.20

-474.51

Tax

197.66

212.75

180.70

197.84

99.46

147.87

113.61

Provisions and contingencies

0.00

Profit After Tax

797.86

635.71

611.14

765.80

-103.73

79.33

-588.12

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

797.86

635.71

611.14

765.80

-103.73

79.33

-588.12

Share in Profit of Associates

11.52

9.51

21.84

24.15

47.56

12.16

364.41

Minority Interest

-35.17

-46.34

-44.25

-234.83

-53.59

-33.55

-75.22

Other related items

0.00

Consolidated Net Profit

774.21

598.88

588.73

555.12

-109.76

57.94

-298.93

Equity Capital

754.96

754.95

Face Value

10.0

Reserves

8,161.56

6,907.94

6,487.30

5,423.28

5,364.85

5,906.13

5,845.85

Earnings per share (EPS)

10.25

7.93

7.8

7.35

-1.45

0.77

-3.96

Diluted Earnings per share

10.26

7.93

7.8

7.35

-1.45

0.77

-4.91

Operating Profit Margin (Excl OI)

20.4%

18.39%

17.49%

18.7%

10.04%

13.16%

5.04%

Gross Profit Margin

17.75%

17.28%

17.59%

22.12%

7.1%

11.2%

-5.41%

PAT Margin

10.4%

9.36%

10.05%

13.82%

-1.39%

1.98%

-5.01%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Mar 2025 is 12.91% vs 9.45% in Mar 2024

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 29.28% vs 1.72% in Mar 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 25.27% vs 15.10% in Mar 2024

Interest

YoY Growth in year ended Mar 2025 is 40.82% vs 1.44% in Mar 2024

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Fortis Health. With

Select Peers

Figures in Cr

Consolidate Annual Results

Change(INR)

Change(%)

Net Sales

7,782.75

21,794.00

-14,011.25

-64.29%

Other Operating Income

0.00

Total Operating income

7,782.75

21,794.00

-14,011.25

-64.29%

Raw Material Cost

1,838.07

2,754.40

-916.33

-33.27%

Purchase of Finished goods

0.00

8,556.70

-8,556.70

-100.00%

(Increase) / Decrease In Stocks

-7.88

-1.10

-6.78

-616.36%

Employee Cost

1,167.24

2,769.20

-1,601.96

-57.85%

Power Cost

0.00

Manufacturing Expenses

1,630.62

0.00

1,630.62

Selling and Distribution Expenses

0.00

Other Expenses

1,566.76

4,693.00

-3,126.24

-66.61%

Total Expenditure (Excl Depreciation)

6,194.81

18,772.20

-12,577.39

-67.00%

Operating Profit (PBDIT) excl Other Income

1,587.94

3,021.80

-1,433.86

-47.45%

Other Income

66.94

200.30

-133.36

-66.58%

Operating Profit (PBDIT)

1,654.88

3,222.10

-1,567.22

-48.64%

Interest

184.41

458.50

-274.09

-59.78%

Exceptional Items

-89.34

0.00

-89.34

Gross Profit (PBDT)

1,381.13

2,763.60

-1,382.47

-50.02%

Depreciation

385.61

757.50

-371.89

-49.09%

Profit Before Tax

995.52

2,006.10

-1,010.58

-50.38%

Tax

197.66

534.00

-336.34

-62.99%

Provisions and contingencies

0.00

Profit After Tax

797.86

1,472.10

-674.24

-45.80%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

797.86

1,472.10

-674.24

-45.80%

Share in Profit of Associates

11.52

33.00

-21.48

-65.09%

Minority Interest

-35.17

-59.20

24.03

40.59%

Other related items

0.00

Consolidated Net Profit

774.21

1,445.90

-671.69

-46.45%

Equity Capital

754.96

71.90

683.06

950.01%

Face Value

10.00

5.00

0.00

Reserves

8,161.56

8,132.60

28.96

0.36%

Earnings per share (EPS)

10.25

100.55

-90.30

-89.81%

Diluted Earnings per share

10.26

100.56

-90.30

-89.80%

Operating Profit Margin (Excl OI)

20.40%

13.87%

0.00

6.53%

Gross Profit Margin

17.75%

12.68%

0.00

5.07%

PAT Margin

10.40%

6.91%

0.00

3.49%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Annual - Net Sales

Net Sales 7,782.75 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 12.91% vs 9.45% in Mar 2024

Annual - Consolidate Net Profit

Consolidate Net Profit 774.21 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 29.28% vs 1.72% in Mar 2024

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 1,587.94 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 25.27% vs 15.10% in Mar 2024

Annual - Interest

Interest 184.41 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 40.82% vs 1.44% in Mar 2024

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 20.40%

in Mar 2025

Figures in %

YoY Growth in year ended Mar 2025 has improved from Mar 2024